This is not a company that avoids anything. I’ve communicated with Mr Dilkes on a number of occasions including within the last 2 weeks.
Perhaps you can appreciate there is a significant workload for the Company at the moment all of which benefits you as a shareholder. Are you unhappy with anything they have have delivered? I’m not.
Also, if you are asking about the trials then you should be aware there is probably nothing they can say to you, particularly if you are inquiring with a view to investing more. IMO there is more than sufficient information to access the opportunity.
Dr Sud Agarwal has a package that is significant above 14 cents, he has appointed the medical board responsible for the trials and his private Company, Cannvalate paid for the majority of the costs associated with these trials.
IHL Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
